Time filter

Source Type

Balch W.E.,Scripps Research Institute | Sznajder J.I.,Northwestern University | Budinger S.,Northwestern University | Finley D.,Harvard University | And 11 more authors.
American Journal of Respiratory and Critical Care Medicine | Year: 2014

Recent discoveries indicate that disorders of protein folding and degradation play a particularly important role in the development of lung diseases and their associated complications. The overarching purpose of the National Heart, Lung, and Blood Institute workshop on "Malformed Protein Structure and Proteostasis in Lung Diseases" was to identify mechanistic and clinical research opportunities indicated by these recent discoveries in proteostasis science that will advance our molecular understanding of lung pathobiology and facilitate the development of new diagnostic and therapeutic strategies for the prevention and treatment of lung disease. The workshop's discussion focused on identifying gaps in scientific knowledge with respect to proteostasis and lung disease, discussing new research advances and opportunities in protein folding science, and highlighting novel technologies with potential therapeutic applications for diagnosis and treatment. Copyright © 2014 by the American Thoracic Society.


Barreiro E.,Institute of Medical Research of Hospital Del Mar IMIM | Barreiro E.,University Pompeu Fabra | Barreiro E.,IMIM Hospital Del Mar | Gea J.,Institute of Medical Research of Hospital Del Mar IMIM | And 2 more authors.
Chronic Respiratory Disease | Year: 2016

Chronic obstructive pulmonary disease (COPD) will be a major leading cause of death worldwide in the near future. Weakness and atrophy of the quadriceps are associated with a significantly poorer prognosis and increased mortality in COPD. Despite that skeletal muscle dysfunction may affect both respiratory and limb muscle groups in COPD, the latter are frequently more severely affected. Therefore, muscle dysfunction in COPD is a common systemic manifestation that should be evaluated on routine basis in clinical settings. In the present review, several aspects of COPD muscle dysfunction are being reviewed, with special emphasis on the underlying biological mechanisms. Figures on the prevalence of COPD muscle dysfunction and the most relevant etiologic contributors are also provided. Despite that ongoing research will shed light into the contribution of additional mechanisms to COPD muscle dysfunction, current knowledge points toward the involvement of a wide spectrum of cellular and molecular events that are differentially expressed in respiratory and limb muscles. Such mechanisms are thoroughly described in the article. The contribution of epigenetic events on COPD muscle dysfunction is also reviewed. We conclude that in view of the latest discoveries, from now, on new avenues of research should be designed to specifically target cellular mechanisms and pathways that impair muscle mass and function in COPD using pharmacological strategies and/or exercise training modalities. © The Author(s) 2016.

Loading Institute of Medical Research of Hospital del Mar IMIM collaborators
Loading Institute of Medical Research of Hospital del Mar IMIM collaborators